4. Vestergaard EM, Hein HO, Meyer H, et al. Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population....
故肝胆疾病中CA19-9 可能非常高。 在胆管结石伴胆管炎的病例中,CA19-9的浓度可超过参考上限1 000倍。除了胆道的良性疾病,胆囊炎是引起CA19-9升高的另一个因素。这表明肝和胆道在代谢与消除 CA19-9 抗原中的具有相应的作用。 在急性及...
随着糖组学分析和人工智能技术的发展,CA19-9在肿瘤微环境解析和个体化治疗中的潜在作用正被逐步揭示,预示着这一经典标志物将在精准医疗时代焕发新的生机。 如需详细了解CA199可阅读这篇文献:CA19-9的前世今生 [1] Lee T , Teng T Z J , Shelat V G .Carbohydrate antigen 19-9 — tumor marker: Past...
肿瘤标志物(Tumor marker, TM)是指在恶性肿瘤的发生和发展过程中,由肿瘤细胞本身产生或由机体对肿瘤细胞反应而产生的一类物质。最常见的肿瘤标志物有AFP、CEA、CA19-9、CA-125、CA-153、PSA、SCC,其中CA19-9单项升高最多见,我们来了解一下。概念糖类抗原19-9(CA19-9):是细胞膜上的糖脂质,在血清中以唾液...
肿瘤标志物CA19-9（Tumor Marker）是反映肿瘤存在的化学类物质。它们或不存在于正常成人组织而仅见于胚胎组织，或在肿瘤组织中的含量大大超过在正常组织里的含量，它们的存在或量变可以提示肿瘤的性质，借以了解肿瘤的组织发生、细胞分化、细胞功能，以帮助肿瘤的诊断、分类、预后判断以及治疗指导。CA19-9是一种肿瘤相关...
CA 19-9水平随着肿瘤分化程度的较差而降低[1].10%- 50%的良性胰腺疾病(如胰腺炎)和前体病变(如导管内胰腺粘液性肿瘤(IPMNs)、胰腺上皮内瘤变)可导致CA 19-9水平升高。因此,独立的CA 19-9水平不能将这些与真正的pdac区分开来。多项研究证实,术前CA 19-9水平随着肿瘤大小、负荷、美国癌症联合委员会分期和病...
CA19-9 has no value as a tumor marker in obstructive jaundice. PMID: 10065510 CA19-9 is a significant prognostic factor in stage III gastric cancer patients undergoing radical gastrectomy. PMID: 38263014 Biomolecular Recognition of the Glycan Neoantigen CA19-9 by Distinct Antibodies. PMID: 3411948...
CA19-9 kinetics during systemic chemotherapy in patients with advanced or recurrent biliary tract cancer. PMID: 29038848 Electrochemical Immunoassay for Tumor Marker CA19-9 Detection Based on Self-Assembled Monolayer. PMID: 35889454 Glycoprotein CA19.9-specific monoclonal antibodies recognize sialic acid-in...
糖抗原19-9(CA19-9)重组蛋白About the MARKER (complimentary) Effective Size Range:10kDa to 70kDa. Protein bands:10kDa, 14kDa, 18kDa, 22kDa, 26kDa, 33kDa, 44kDa and 70kDa. Double intensity bands:The 26kDa, 18kDa, 10kDa bands are at double intensity to make location and size approxima...
CA19-9 kinetics during systemic chemotherapy in patients with advanced or recurrent biliary tract cancer. PMID: 29038848 Electrochemical Immunoassay for Tumor Marker CA19-9 Detection Based on Self-Assembled Monolayer. PMID: 35889454 Glycoprotein CA19.9-specific monoclonal antibodies recognize sialic acid-in...